Based on the excerpt you provided, the press release announces that Skye Bioscience reported its Q2 2025 financial results and highlighted various operational achievements. However, the summary does not include any information about the company's internal guidance (e.g., revenue, earnings, cash burn, or any other metric) nor does it state whether the actual results were above, below, or in line with that guidance.
Therefore, with the information available in the news excerpt you shared, we cannot determine whether Skye Bioscience met, exceeded, or fell short of its internal guidance for the quarter. Additional details from the full press release, an earnings call transcript, or other investor‑relations materials would be required to answer that question definitively.